Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong · Delayed Price · Currency is HKD 59.80
-0.50 (-0.83%)
At close: May 14, 2026
Suzhou Ribo Life Science Revenue
In the year 2025, Suzhou Ribo Life Science had annual revenue of 148.51M CNY with 4.12% growth. Suzhou Ribo Life Science had revenue of 44.70M in the half year ending December 31, 2025.
Revenue
148.51M CNY
Revenue Growth
+4.12%
P/S Ratio
62.23
Revenue / Employee
364.89K CNY
Employees
407
Market Cap
10.28B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 148.51M | 5.88M | 4.12% |
| Dec 31, 2024 | 142.63M | 142.58M | 324,052.27% |
| Dec 31, 2023 | 44.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hopson Development Holdings | 30.50B |
| Hangzhou SF Intra-city Industrial | 25.48B |
| China Resources Building Materials Technology Holdings | 23.41B |
| Tiangong International Company | 5.25B |
| LifeTech Scientific | 1.52B |
| Seyond Holdings | 1.20B |
| Plover Bay Technologies | 1.01B |
| SY Holdings Group | 1.01B |